Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery

Condition(s) studied

Investigational drug(s) / intervention(s)

Moxifloxacin: Intracameral injection

Placebo: intracameral injection

Study summary

Intracameral injection of 0.1% moxifloxacin solution after cataract surgery to prevent endophthalmitis

Eligibility

Primary outcome measure(s)

• Endophthalmitis after cataract surgery — Subjects will undergo eye examinations at one day, one week, and one month post-operatively
  Subjects will be followed after cataract surgery and have post-operative eye examinations to determine if infection in the eye (endophthalmitis) occurs during the study period.

Trial sites (1)